The Cheaper Quote Often Costs More

When two reagent quotes land on a desk, the temptation is to scan the unit price, take the cheaper one, and move on. It feels efficient. It also quietly drains budgets, because the number on a vendor's quote is rarely the number that ends up in the general ledger.

The gap between those two figures is what procurement teams call total landed cost: the full, all-in cost of getting a reagent from a supplier's warehouse onto the bench and into a usable state. For labs running on tight margins, that gap is the difference between a purchase that looks smart on paper and one that's profitable in practice.

Here's what total landed cost includes, a worked example where the cheaper quote loses, and a way to build the discipline into ordering without an ERP overhaul.

The one-line definition

Total landed cost is the sum of every cost incurred between the moment a lab commits to buying a reagent and the moment that reagent produces a billable result.

What total landed cost actually includes

The purchase price is the starting point, not the finish line. Around it sit a stack of costs that often never appear on the original quote:

• Freight and shipping. Ground freight, expedited shipping when a stockout forces a rush, and fuel surcharges. Dry-ice or refrigerated shipments carry meaningfully higher freight than ambient items.

• Cold chain and handling. Antibodies, enzymes, controls, and calibrators that need validated 2 to 8°C or frozen shipping often carry separate cold-pack fees, hazmat charges, and Saturday-delivery surcharges.

• Customs, duties, and brokerage. For imported reagents (a large share of immunoassay and molecular consumables), duties, tariff classifications, and broker fees can add 3 to 8% on top of the invoice, and rarely show on the quote.

• Insurance. Cargo insurance on high-value or temperature-sensitive shipments, sometimes bundled into freight, sometimes broken out.

• Inventory carrying cost. Capital tied up, refrigerator and freezer space, electricity, and expiry risk. A useful rule of thumb is 18 to 25% of inventory value per year. A reagent bought six months early and half-consumed before expiry costs far more than its invoice suggests.

• Quality and acceptance. Receiving inspection, lot-to-lot validation, parallel testing, and documentation. For regulated labs (CLIA, CAP, ISO 15189), every new lot can trigger formal verification that consumes tech time.

• Waste and obsolescence. Reagents that expire, fail QC, or are scrapped after a method change. A minimum order quantity (MOQ) set above true usage is a silent transfer of waste cost onto the lab.

• Payment terms. Net-15 versus Net-60 changes the working-capital cost of a purchase. A 1% discount for paying in 10 days (the classic 1/10 net 30) works out to roughly 18% annualized, usually worth taking.

• Returns, credits, and disputes. Damaged shipments, short-dated lots, and miscounts all consume staff time. Some vendors make credits painless; others turn every claim into a multi-week negotiation.

A worked example

Take two quotes for the same chemistry reagent kit, 12 cartridges per case.

Vendor A quotes $480 per case, ships ground from a regional warehouse, folds in cold-pack and hazmat fees, offers Net-30, and delivers in one to two days, with an MOQ of a single case. Vendor B quotes $420 per case, a $60 saving on paper, but requires a four-case minimum, adds a $45 cold-shipping fee per shipment, wants Net-15 prepay, and ships from overseas on a three-to-four-week lead time with a 4% import duty.

On unit price alone, Vendor B looks like a 12.5% saving. The landed-cost math tells a different story:

That is still a saving, about 6.7% rather than 12.5%, but only if all four cases are consumed before the earliest-dated lot expires. If a single case expires unused, the effective cost on the three usable cases jumps to $597.40 per case: 24% more expensive than Vendor A. The four-week lead time also forces roughly a month of extra safety stock, with all the carrying cost that brings.

The central lesson: a lower unit price on a larger order shifts cost from the invoice onto inventory, cash flow, and expiry risk. Sometimes the math works. Often it doesn't.

Where labs most often underestimate it

A few patterns show up again and again in procurement reviews:

• Treating expedited shipping as an emergency, not a cost. Rushing reagent orders more than once a quarter means the surcharges aren't outliers; they're a structural cost that belongs in the standing vendor's landed cost.

• MOQ-driven over-purchasing. A reagent with nine-month dating, an MOQ of 10 units, and true usage of 6 units a year is a guaranteed write-off on units 7 through 10.

• Freight blindness. Labs negotiate hard on the line price, then accept whatever freight terms come with it. Freight, carrier, and service level are all negotiable.

• Ignoring the cost of poor quality. A lot that fails QC and forces a re-run wastes reagent, tech time, instrument time, and turnaround commitments. A vendor with a 2% lot-failure rate and one at 0.2% are not comparable on price alone.

Building it into the workflow

No ERP overhaul is required to start. Three disciplines do most of the work.

First, keep a per-SKU landed-cost factor: a multiplier that converts a quote price into expected all-in cost. Track actuals for a few months (invoice, freight, duties, waste, rework), and the ratio of total cost to invoice price becomes a vendor-specific factor to apply to future quotes. Most labs find these factors run from about 1.05 (a domestic vendor with included freight, reliable lots, and right-sized MOQs) to 1.30 or more (an overseas vendor with cold chain, duties, long lead times, and minimum buys that force overstock). Two quotes that look identical on the line item can land very differently once the factor is applied.

Second, evaluate vendor changes on a 12-month basis, not per order. Switching reagent vendors carries one-time validation, training, and parallel-testing costs that a single-shipment comparison ignores. A vendor that's 5% cheaper per case but requires $4,000 of validation work needs enough annual volume to repay that switching cost before the savings are real.

Third, treat lead time as a cost, not just a logistics fact. Every day of lead time forces either more safety stock (carrying cost) or more stockout risk (rush shipping, or worse, lost revenue from missed turnaround). A vendor offering two-day shipping at a slight premium often beats one with three-week lead times once the safety stock is priced in.

Bottom line

Total landed cost reframes purchasing from a comparison of prices into a comparison of outcomes. It rewards vendors who reduce work, risk, and waste, and penalizes those who push cost into corners of the operation that never show up on a quote. For diagnostic labs, where reagents typically run 20 to 35% of revenue, even a few points of landed-cost discipline drop straight to the bottom line.

So when the next quote arrives, the question worth asking isn't which unit price is lower. It's what it will actually cost to have that reagent ready on the bench, in spec, on the day it's needed. That number, the landed cost, is the only one that matters.

 

---

 

Want JIT4Labs to price it out?

JIT4Labs catalogs reagents from Beckman Coulter, Siemens, Abbott, and more, with cold chain included, domestic stocking, and right-sized MOQs built for independent diagnostic labs.

Browse the catalog: jit4labs.com

Published by the JIT4Labs Procurement Desk, part of the Lab Operations Resource Series. JIT4Labs is not affiliated with or authorized by any reagent manufacturer.